Lithium: Potential Therapeutics Against Acute Brain Injuries and Chronic Neurodegenerative Diseases
In addition to the well-documented mood-stabilizing effects of lithium in manic-depressive illness patients, recent in vitro and in vivo studies in rodents and humans have increasingly implicated that lithium can be used in the treatment of acute brain injuries (e.g., ischemia) and chronic neurodege...
Saved in:
Main Authors: | Akihiko Wada (Author), Hiroki Yokoo (Author), Toshihiko Yanagita (Author), Hideyuki Kobayashi (Author) |
---|---|
Format: | Book |
Published: |
Elsevier,
2005-01-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Mechanisms and Drug Development in Aquaporin Water Channel Diseases: Aquaporins in the Brain
by: Hideyuki Kobayashi, et al.
Published: (2004) -
New Twist on Neuronal Insulin Receptor Signaling in Health, Disease, and Therapeutics
by: Akihiko Wada, et al.
Published: (2005) -
Lithium and Neuropsychiatric Therapeutics: Neuroplasticity via Glycogen Synthase Kinase-3β, β-Catenin, and Neurotrophin Cascades
by: Akihiko Wada
Published: (2009) -
Brain Injury as a Neurodegenerative Disorder
by: Robin E.A. Green
Published: (2017) -
Drug Development Targeting the Glycogen Synthase Kinase-3β (GSK-3β)-Mediated Signal Transduction Pathway: The Role of GSK-3β in the Maintenance of Steady-State Levels of Insulin Receptor Signaling Molecules and Nav1.7 Sodium Channel in Adrenal Chromaffin Cells
by: Takayuki Nemoto, et al.
Published: (2009)